CryoLife, Inc. (CRY)

Good value. On the rise.

Following streetflame with this one.
See pitch by TSIF.
I usually avoid biotech, but this one seems different.

http://seekingalpha.com/article/169419-updates-on-access-pharma-biosphere-medical-cryolife-neopharm?source=feed

This company will rebound

See my October 2009 blog post:
http://caps.fool.com/Blogs/ViewPost.aspx?bpid=281934&t=01001638641678935351

See my October 2009 blog post:
http://caps.fool.com/Blogs/ViewPost.aspx?bpid=281934&t=01001638641678935351

What more can I say-TSIF did the D&D, and I agree-is a buy or at least a green thumb

Cryolife is an interesting pick for me. Most pharmaceutical/bio type companies with products in development are playing roulette with the quirky FDA, buring through cash, and hoping for either a win, a buyout, or both. CryoLife differs in that they have been around for decades, cash positive. A years worth of News articles show very little besides the typical SEC filings and Motley Fool playing the trumbone with "high/low" note articles. An " implantable biological medical device and cardiovascular tissue processing company" should be a little more interesting, but it's BIOGLUE product just keeps on quietly sticking. Recent FDA approval for a human heart patch shows that CryoLife has continued innovating and is not quite content with stickly profits on glue. With only a $15 Million market opportunity for the new patch used primarily in adolescent ventrical issues, it's hard to follow the renewed interest, but as with other companies with medical related products, an opening in one area of FDA approval could signal related products. For me, it highlighted that CryoLife was currently undervalued by the market, new products or not. Profit margin of 28%, ROE of 34%, no debt, low P/E. If CryoLife's next five years are as good as it's last then I'll be very happy with the shares I bought a few weeks ago.

from scottrade

A no brainer. Enormous value, in a sector on the rise. With McDonalds's (MCD) climbing, cardiovascular tissue will be in sky-scraping demand! Look out, Cryolife's on the move and packing heat, BioFoam heat that is.

Great Fundamentals with services that will be needed much more in the future. Currently undervalued. The management seems to be focus on sales and growth. Mid-Longterm Investment. IMHO

Considering Book value, earnings, and market cap...this should beat the market in 5 years.

I can't find any reason why this stock is Down??? It appears to be well managed. ( CGQ Ratios are 93% Better than S&P 600 & 93% Better than other Health Care Co's. It has a Fantastic Line of Products ( in addition to "parts" like tissue & heart valves-- it also has BioGlue, ProPatch & CardioWrap.) --which it sells internationally. It has GREAT Profits & ROE --- Best of all...it has almost NO Debt !!!

big discounted stock

First of all, the bioglue and tissue preservation services will only become more valuable in the future. The demand for such things will only increase with the population, and although the share price has fallen, the true value of the company will eventually be recognized. This, however, is only my first impression of the company and is merely my own personal opinion. Take from it what you will.

Cryolife also seems focused on putting their products in more doctors and specialists hands. The most recent presentation at the Sidoti's Forum shows their intent to more aggressively market their goods. The 51 person sales team has been aimed directly at cardiac and vascular surgeons. Management also seem s focused on protecting/expanding their core markets.

I believe we will see a turnaround by next quarter with continuous growth for a long while thereafter. Let's just hope there isn't another lawsuit filed against them over bad tissue again.

Outperform 1Y.

bio glue.

Great industry, great fundamentals.

Strong fundamentals.

The recession is just beginning, so look for sectors that do not depend on business growth: health care is an excellent candidate.